Tom ntej: Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate CAS 74892-82-3 Argatroban Intermediate High Purity

Lus piav qhia luv luv:

Lub npe: Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate

CAS: 74892-82-3 Nr

Cov tsos mob: Ntshiab rau lub teeb daj daj

Purity: ≥98.0% (GC)

Intermediate ntawm Argatroban, Ib tug Synthetic Antithrombotic Agent

High Quality, Commercial Production

E-mail: alvin@ruifuchem.com


Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Chemical Properties:

Tshuaj npe Ethyl (2R, 4R)-4-Methyl-2-Piperidinecarboxylate
Synonyms Ethyl (2R,4R)-4-Methylpipecolate;(2R,4R)-4-Methyl-2-Piperidinecarboxylate;(2R,4R)-Ethyl 4-Methylpiperidine-2-Carboxylate;Ethyl-(2R,4R)-4-Methylpiperidine-2-Carboxylate
CAS Nr 74892-82-3
CAT Number Qauv TSIS MUAJ: RF-PI267
Tshuag xwm txheej Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula C9H17 NPO 2
Molecular Luj 171.24 Nws
Shipping Condition Shipped nyob rau hauv ambient kub
Hom Ruifu Tshuaj

Specifications:

Yam khoom Specifications
Qhov tshwm sim Ntshiab rau Lub Teeb Yellow Liquid
Diastereoisomer ≤ 1.0%
Purity / Analysis Method ≥98.0% (GC)
Hnyav Hlau ≤ 20ppm
Test Standard Enterprise Standard
Kev siv Argatroban Intermediate (CAS 74863-84-6)

Pob & Cia:

Pob: Lub raj mis, chim, 25kg / chim, los yog raws li tus neeg yuav tsum tau muaj.

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb, noo noo thiab kab tsuag.

Qhov zoo:

1

FAQ:

Daim ntawv thov:

Shanghai Ruifu Chemical Co., Ltd. yog cov chaw tsim khoom thiab cov chaw muag khoom ntawm Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate (CAS: 74892-82-3) nrog cov khoom zoo.Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate (CAS: 74892-82-3) yog ib qho nruab nrab feem ntau hauv kev sib txuas ntawm Argatroban Monohydrate (CAS 141396-28-3) lossis Argatroban (CAS 74663-8) ).

Argatroban Monohydrate yog ib qho tshwj xeeb thrombin inhibitor, uas yog non-heparin anticoagulant, tiv thaiv kev tsim ntawm thrombi.Argatroban yog ib qho anticoagulant uas yog ib qho me me direct thrombin inhibitor.Xyoo 2000, argatroban tau ntawv tso cai los ntawm Food and Drug Administration (FDA) rau kev tiv thaiv lossis kev kho mob thrombosis hauv cov neeg mob uas muaj heparin-induced thrombocytopenia (HIT).

Sau koj cov lus ntawm no thiab xa tuaj rau peb